The RFP Database
New business relationships start here

Linguamatics IE2 software licensing, related products and services


Maryland, United States
Government : Federal
RFP
Go to the link
This document has expired, therefore the above link may no longer work.

Request for Information and Response Cover Sheet
RFI # FDA-RFI-19-1208769
RFI Title Linguamatics IE2 software licensing, related products and services
RFI Due Date
Company Name
Website URL
Address
Phone
DUNS Number
Size Status
How product can be procured?
OEM Name
DUNS Number
Size Status
Contact Name
Email Address
Address (if different from company address)
Phone Number
Cell Number (optional)

Request for Information

"This is a Request for Information (RFI). This is NOT a solicitation for proposals or quotations. This notice is for information, planning and market research purposes only and shall not be construed as either a solicitation or obligation on the part of the Food and Drug Administration or its Centers."


Responses to this RFI will be treated as information only. This RFI is solely for gathering information and is not a Request for Quotation or a Request for Proposal (RFQ/RFP). Responses to this notice cannot be accepted as offers. No entitlement to payment of direct or indirect costs or charges by the Government arises as a result of submitting responses to this RFI or the Government's use of submitted information.


Vendors should clearly identify any proprietary information contained within the response so that it may be handled appropriately. The Government will not return responses to this RFI, nor provide any information regarding this requirement.


Background


The Division of Applied Regulatory Science (DARS) located within CDER's Office of Translational Science (OTS) conducts laboratory research on drug safety and efficacy to support the review, approval and monitoring of new therapeutics. Central to this work is the mining of laboratory data and document text to understand the cellular and molecular pathways involved in drug action, and the use of this information in simulating and predicting clinical outcomes. Text mining and interaction mapping tools are an essential part of interpreting science data and predicting clinical response.
General Information
The objective is to acquire Concurrent User Licenses for a Natural Language Processing (NLP) software platform that will to allow data mining of FDA internal documents and external literature sources such as FDA Drug Labels, MEDLINE and other databases. The NLP toolkit is intended to use semantic text mining to rapidly analyze document to find therapeutically useful and possibly unknown associations between drugs, disease processes, adverse events and therapeutic targets.
In 2012, DARS began using an online version of Linguamatics then moved to server based concurrent licensed version in 2015 as interest in using the software increased within OTS. The FDA is seeking Linguamatics or similar software that can provide the same capabilities.

No basis for claims against the United States government shall arise as a result of a response to this request for information or from the United States government's use of such information. Proprietary, classified, confidential, or sensitive information should not be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
Responses should be emailed to tzeleong.chang@fda.hhs.gov no later than 5:00 PM Eastern Time, April 9, 2019.
Questions to be answered:
1. Vendors should complete the cover page with their RFI submission.
2. Please provide documentation of the size of your business. If you are classified as a small business, Historically Underutilized Business Zone small business, Service Disabled Veteran Owned Small Business, Woman-Owned Small Business and/or SBA 8(a) certified small business, please provide a capability statement in addition to the other information for acquisition strategy determination. Additionally, please demonstrate your firm's capability to meet the requirements of FAR 52.219-14, Limitations on Subcontracting.
3. What Linguamatics or equivalent Software can you provide to fulfill FDA's requirement? Are you the developer of this software or an authorized reseller?
4. What are the quantities or ranges of quantities the Government can receive from economical discounts when the FDA purchase greater amount of quantities for both product and services?
5. Do any gaps exist in the Draft Statement of Works? If so, what are they? What changes, additions, updates, and clarifications would you suggest?
6. Any questions that you may have regarding to this RFI. No responses will be provided to any questions asked.
7. By responding to this RFI, the vendor gives consent to the Government to share their responses with Contractors assisting with the development of and performing requirements analysis for this requirement. Vendors who will not give consent to the Government to share their responses with Contractors may result in the Government's inability to determine their capabilities and will be deemed as not capable of performing this requirement. Will you give consent to the Government to share your responses with Contractors assisting with the development of and performing requirements analysis for this requirement?


Attachments:
Statement of Work


 


Steven Chang, Contract Specialist, Phone 240-402-7527, Email Tzeleong.Chang@fda.hhs.gov

    1. Home
    2. Articles
    3. Login or Register

    4. Search

    5. Add/Announce your RFP